Auleon Biologicals
News
09
2017
-
11
Vaccine product homogenization, dynamic insurance enterprises rely on what to win?
Author:
(pig pocket-scale e pig Wang Enhui) in this era of resource integration and common development, merger and reorganization, joint cooperation and complementary advantages among enterprises are common, especially in the dynamic insurance industry. In 2015, Huapai Bioengineering Group successfully controlled Chongqing Aolong Biological Products Co., Ltd. and invested more than 0.2 billion yuan to build 5 live vaccine production lines. This has given new vitality to Aolong Bio, which has been established for nearly 10 years. It is expected that in 2017 Aolong Bio will achieve sales revenue of 0.13 billion yuan. Ten years to build a dream, the road to reach far, Aolong biology is step by step from "excellent" to "excellent".
At present, the homogenization of vaccine products in the animal protection industry is very serious, how do animal protection enterprises rely on to win the market? Where will the future development direction go? With these questions, our reporter interviewed Fu Gang, general manager of Chongqing Aolong Biological Products Co., Ltd. (hereinafter referred to as "Aolong Biological"). Perhaps, through his persistence in China's animal protection industry for nearly 30 years and his deep understanding of the animal protection industry, we can get some inspiration.
Fu Gang, General Manager of Chongqing Aolong Biological Products Co., Ltd.
Impression "Aolong"
Aolong Biological is located in Chongqing Rongchang High-tech Industrial Development Zone. It is a modern high-tech enterprise engaged in the research and development, production, sales and technical services of animal biological products. After Huapai Bioengineering Group Holdings in 2015, newly built 5000 square meters of live vaccine workshop for livestock products (absolutely negative pressure Brucella production line, independent sheep hydatid genetic engineering vaccine production line, cell suspension culture production line, cell vaccine production line), 3500 square meters of inactivated vaccine workshop for livestock products (bacterial inactivated vaccine production line, cell inactivated vaccine production line), 4500 square meters of quality inspection and research center (including P3 laboratory), 6000 square meters of pigs, cattle, sheep and rabbits laboratory animal center, 5000 square meters of administrative office center and other supporting facilities, it has advanced high-density bioreactors at home and abroad, imported suspension culture equipment, modern washing and drying linkage packaging lines, imported freeze dryers and advanced inspection equipment. It has 13 product approval numbers and an annual production capacity of 1.5 billion. At present, the main products include sheep echinococcosis (hydatid) disease genetic engineering subunit vaccine, brucellosis live vaccine (S2 strain, A19 strain), swine fever live vaccine, pseudorabies live vaccine, swine Japanese encephalitis live vaccine, etc. Among them, sheep echinococcosis (hydatid) disease genetic engineering subunit vaccine is recognized as "the world's first and only domestic" national class of new veterinary drugs by the Ministry of science and technology.
Entering Chongqing Aolong Biological Products Co., Ltd.
Product quality first
"For long-term development of animal insurance enterprises, product quality is the first priority." General Manager Fu Gang said in an interview with our reporter. He further explained, "Product quality is the lifeline for enterprises to survive, and high-quality products are inseparable from the strict control of product quality by enterprises. The second is the rational layout of the product structure. The products should not be many and miscellaneous, but should be concentrated, which will be more competitive; on this basis, it is necessary to strengthen value-added services, no matter which industry is the production enterprise, if it cannot provide users with High-quality services are difficult to occupy the market."
This is exactly what Aolong creatures practice. From the beginning of its establishment, Aolong Bio insisted on producing safe and efficient vaccine products. This is not only due to the continuous strengthening of the national supervision of the animal vaccine industry, the increasing public concern about the safety of animal vaccine products, but more importantly, it comes from the requirements of the enterprises themselves. Fu Gang to swine fever vaccine as an example, about the Australian dragon biological vaccine product quality excellence pursuit. Aolong biological swine fever vaccine, not only the product is pure, no exogenous virus and mycoplasma pollution, and the antigen content is high, the effective ingredient is much higher than the national standard, in the peer is also among the best. Not only that, the product also uses low serum suspension culture technology, through purification treatment, to remove endotoxin, serum, cell debris, etc., to ensure the safety of swine fever vaccine products, pigs after vaccination basically no stress response.
In the face of the increasingly serious problem of homogenization of vaccine products, Fu Gang said with deep feeling, "classical swine fever vaccine is the most homogenized product in the biological products industry, as a slang saying: 'black-haired pigs, every family', almost all domestic biological products enterprises have classical swine fever vaccine products." Even in the face of such fierce competition, Aolong creatures still have great achievements. During the period of political bidding, the government purchased more than 0.1 billion copies of classical swine fever vaccine every year, and the sales volume of market-oriented classical swine fever vaccine also reached tens of millions of copies. In 2015, Aolong biological realized product sales revenue of 12.8 million yuan, reached 98 million yuan in 2016, and is expected to reach 0.13 billion yuan this year. In Fu Gang's view, Aolong Bio can achieve such results, thanks to the excellent quality of vaccine products.
Vaccines are the main means of disease control at present. With the continuous development of the aquaculture industry, the requirements for the quality of vaccine products and technical services are getting higher and higher. In recent years, the quality of Aolong biological products has continuously leapt to a new level. In 2014, Aolong biological launched a one-shot classical swine fever vaccine, which reduced the number of epidemic prevention and immune stress of farmers, improved feed remuneration and production efficiency, and quickly accumulated a good reputation after taking the lead in listing in South China. In order to improve the service level, Aolong biological has set up a professional technical service team composed of experts, professors and masters of veterinary medicine, and added a number of technical service vehicles to provide technical services for farmers nationwide. In 2016, Aolong Bio also launched an online remote diagnosis platform to provide farmers with a full range of online and offline services, to meet the needs of farmers in various places to the greatest extent, and to help farmers solve pigs in a timely, accurate and efficient manner. Technical problems encountered in the process.
While paying attention to the quality of vaccines, Aolong Bio has also continuously increased its investment in research and development. Relying on Southwest University, the company has established close technical cooperation with the Royal New Zealand Academy of Sciences, Chinese Academy of Agricultural Sciences, China Agricultural University, China Veterinary Drug Control Institute, Chongqing University, Sichuan Agricultural University, Southwest University, Beijing Institute of Animal Husbandry and Veterinary Medicine and other well-known teaching and research institutes. At present, it has a R & D team of more than 20 people composed of 3 doctors and 12 masters. It has strong product R & D technology and has obtained more than 30 national invention patents and practical patents. According to Fu Gang, in terms of new product research and development, Aolong Bio adheres to the combination of independent innovation, joint research and development and technology introduction. The annual research and development expenses for new products and new processes account for 10%-15% of sales revenue. In order to enrich the product categories, Aolong Bio has increased its R & D investment in the past two years. Since last year, Aolong Bio has invested about 0.1 billion yuan in technology transfer and R & D.
Chongqing Aolong Biological Products Co., Ltd. R & D Center
Force swine fever vaccine market
Classical swine fever is widely popular all over the world. Although China has made great achievements in the scientific research and prevention and control of classical swine fever, it is still an important disease affecting and endangering pig production in China. In 2017, the Ministry of Agriculture announced that swine fever and blue ear would withdraw from the national compulsory immunization program 10 years after the implementation of the compulsory exemption policy. It is also required that by the end of 2020, all pig farms and some regions in the country will meet the purification standards for swine fever and blue ear. In March 2017, the Ministry of Agriculture issued the "National Swine Fever Prevention and Control Guidance (2017-2020)", requiring all localities to continue to implement swine fever immunization against live pigs, further implement various comprehensive prevention and control measures, and effectively control and gradually eliminate swine fever.
In this regard, Fu Gang said frankly, "the purification of classical swine fever is imperative, however, the ideal is very plump, the reality is very skinny, with the reality of China's pig industry, it is too difficult to purify classical swine fever within 10 years."
How big is the impact of policy adjustment on Australian dragon creatures? Fu Gang replied: "The country's cancellation of government bidding for swine fever and Blue Ear is an opportunity and a challenge for us. The marketization of classical swine fever vaccine will release a huge market space, and production enterprises can compete fairly, and they must also use product strengths and technical services to compete for the market and occupy the terminal. This is a challenge for companies that started relatively late, because established companies already have a certain degree of visibility and occupy a certain market share. However, Aolong Bio has always looked at the market from the perspective of development. Our vaccine products are of excellent quality, and our technical services have also implemented online and offline all-round three-dimensional services. Moreover, we have put forward the slogan of" one shot of immunization, lifelong benefit ". This is not only a slogan, but also a commitment to farmers. In other words, only one shot of swine fever vaccine needs to be given to pigs to provide protection until they are released. This is because Aolong swine fever antigen is pure and safe, with high antigen content (≥ 30000RID), imported heat-resistant protective agent can ensure easier transportation of antigen, unique diluent can ensure the effect of swine fever vaccine, patented drinking water agent can minimize the interference of external factors on swine fever vaccine, and only one shot of immunization is needed, saving time, labor, high efficiency and less stress."
Fu Gang also analyzed many difficulties in the purification of swine fever in pig farms. He believes that the introduction, pig circulation is an important factor leading to swine fever difficult to purify. Due to the prevalence of persistent infection of classical swine fever virus in pigs in China, and the hidden infection of pigs do not show clinical symptoms, easy to be ignored, if the introduction of non-quarantine or quarantine is not strict, it is possible to introduce toxic pigs. In addition, the widespread epidemic of swine fever is directly related to the circulation of commercial pigs across regions, frequent introduction across regions, and introduction of piglets.
"We are duty-bound to purify swine fever." Fu Gang said, "Aolong Biology will continue to help pig farms control and purify swine fever." It is reported that in 2017, the "Chongqing Aolong Swine Fever China Tour" event has been held 8 times across the country, and the event will continue until next year.
Opportunity
China's pig industry after decades of development, the scale is growing. Fu Gang pointed out, "At present, the number of breeding sows in the country is close to 40 million, and the annual number of live pigs is more than 0.8 billion." Accordingly, the market space for vaccines for pigs is huge.
The reporter learned that at present, Aolong biological sheep echinococcosis genetic engineering subunit vaccine sales in the national market accounted for the first, brucellosis live vaccine sales in the top five, pig vaccine is also the key direction of Aolong biological development, in addition to swine fever vaccine, Aolong biological will also launch porcine transmissible gastroenteritis-porcine epidemic diarrhea live vaccine, porcine circovirus-mycoplasma pneumonia two inactivated vaccine and other products. Among them, the live porcine transmissible gastroenteritis-porcine epidemic diarrhea vaccine is expected to be launched in 2018. Fu Gang told reporters that the vaccine strain is a new strain and has a high degree of matching with the current epidemic strain.
"Protecting animal health is the mission of animal protection enterprises. At present, China's aquaculture industry is in the stage of transformation to advanced farming concepts and models, and the concept of breeding more important than prevention and prevention more important than governance is becoming more and more popular, and with the increasing scale and intensification of the aquaculture industry, the animal protection industry will also face a major reshuffle." Fu Gang said when talking about the development trend of the mobile insurance industry.
In the future, Aolong Bio will continue to adhere to the enterprise goal of "creating the future with high biological technology and casting Aolong with 100 years of quality", and in line with the enterprise concept of "diligence can be owned, innovation can be long-term", and make efforts in the research and development of vaccine products and related kits for pigs, cattle and sheep. In addition to developing vaccines for current epidemics, Aolong Bio is also concerned about new epidemics. According to Fu Gang, Aolong Biology and Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences are jointly developing an African swine fever vaccine.
"In the face of the current development trend of animal vaccines, genetic engineering vaccines are the general trend." Fu Gang is very optimistic about the development prospects of genetically engineered vaccines. He told reporters that genetically engineered vaccines are safe and can avoid the risk of dispersal of traditional vaccines. They are also efficient, the production process is not complicated, and the production cost is reduced. The advantages are obvious.
From another point of view, genetic engineering vaccines have large investment, long research and development cycle, and many technical bottlenecks, and are not easy to be copied or imitated by other followers. Once the research and development is successful, the vaccine product is innovative and can become a "sharp weapon" for enterprises to win the market. it will undoubtedly help mobile insurance enterprises to resolve the competitive pressure brought about by product homogenization.
Brand Dream
If we say that excellent product quality and super high sales are the hard power of an enterprise, then excellent corporate culture and brand concept are the soft power to guide the enterprise forward.
Over the years, Aolong Biology has followed the corporate culture concept of "unity, pragmatism, enterprising and innovation", and has never slackened on the road of ensuring my country's public health safety and the healthy development of animal husbandry.
Brand is the most important intangible asset of an enterprise. The power of brand can bring amazing brand value, and it can also help the enterprise crisis in the invisible. In recent years, some of the awareness of advanced mobile insurance companies with the help of the power of the brand, has achieved a competitive advantage and even rapid forward. Conversely, animal insurance companies can only become stronger and bigger if they provide good product brands and good reputation for the aquaculture industry.
Fu Gang firmly believes that improving product quality is the basis for building a brand. "In recent years, Aolong Bio has continuously consolidated its foundation in product quality, sales and technical services, and has gradually formed Aolong Bio's own characteristics to consolidate and develop the market." Fu Gang said, "Those who travel a hundred miles are half and ninety. In the future, we will continue to pursue the corporate tenet of 'making well-known products for the benefit of humanity', and strive to build the 'Aolong' brand, and promote 'Aolong' to the whole country and the world."
Interview Notes: Believe in the power of the brand
Some people say that in the future, the pace of reshuffle of animal protection enterprises will even be faster than that of feed enterprises, and the surviving animal protection enterprises will face the tests of technological innovation, service innovation, market channel competition and so on. In any case, as long as competition exists and product homogeneity exists, enterprises need to create brands. And good product quality is necessarily the basis for building a brand.
Believe in the power of the brand. Shortly after the author completed this interview, something happened: McDonald's changed its name to "Golden Arch", which triggered an online carnival. After the netizens mocked the group, they changed the brand names of other tall brands to look like local products coming out of the village. According to the data obtained by the author, McDonald's ranked 10th with a brand value of 97.723 billion US dollars in the "2017 BrandZ Top 100 Most Valuable Brands in the World" released in June 2017. It is precisely because of its huge brand value that McDonald's official response to the change of name is only at the license level, the brand name has not changed, and the restaurant is still "McDonald's".
Just as the 19th National Congress of the Communist Party of China has just concluded, I still remember that on the opening day, General Secretary Xi Jinping mentioned in a report of more than 30000 words that "a hundred miles is half and ninety". What he said at that time was: The great rejuvenation of the Chinese nation is by no means easy. It can be achieved by beating gongs and drums, and the whole party must be prepared to make more arduous and arduous efforts. In this interview with General Manager Fugang of Aolong Biology, I heard this sentence again and felt the same way. Indeed, the establishment of a brand requires great patience and is a difficult road. Even in such a journey, Aolong Biology has gone through ten years of trials and hardships. In the future, Aolong Biology will not stop moving forward.
This article is reproduced from the pig pocket network
Latest Blog
2024-08-22
"Passion Foying Gorge Swims in the Water World"-A Documentary of Aolong Biology 2024 'Gratitude Tour
From August 15 to 18, 2024, Chongqing aolong biological products co., ltd. successfully held the "passionate Buddha shadow gorge swimming in the water world"-aolong biological 2024 'cohesion and gratitude tour group building activity,
2024-08-14
Huapi Bio Group, a leading company in mobile insurance, completed its first financing, with Guoxin Hongsheng, a well-known industrial party and Jinmu Capital participating in the investment, and Kaby Capital acting as the sole financial advisor.
Recently, Huabai Biotechnology (Group) Co., Ltd. (referred to as "Huabai Bio") completed its first financing.
Thank you for visiting the official website of Chongqing Auleon Biologicals. If you have cooperation intentions or suggestions, please contact us through the following methods, and we will give you feedback in time, thank you!
Marketing Center: +86-023-46761801
Technical Services: +86-023-46763511
HR: +86-023-46763267
International Trade: +86-023-46763211
Address: (No.5, 4th Branch Road) National High-tech Industrial Park, Rongchang District, Chongqing, China
© 2024 Chongqing Auleon Biologicals Co., Ltd. 
渝公网安备50022602000038号